Schedule 13G ownership disclosure
Ultragenyx Pharmaceutical Inc
Security class unavailable · CUSIP: 90400D108
Event date: 2018-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 5,996,082
- Percent of class
- 11.8500%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902219-19-000047
- Form type
- SC 13G
- Filer
- Ultragenyx Pharmaceutical Inc.
- CIK
- CIK 1515673
- Filed
- Feb 12, 2019
- Reporting period
- Dec 31, 2018
- Description
- Schedule 13G beneficial ownership